Latin American Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin American Newswire.

Press releases published on March 30, 2026

Mar. 30, 2026

Tempest Reports Year End 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Mar. 30, 2026

Clearmind Medicine Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder

Indeterminate GlobeNewswire

Mar. 30, 2026

Aprea Therapeutics Announces Oversubscribed $30 Million Private Placement

Indeterminate GlobeNewswire

Mar. 30, 2026

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Mar. 30, 2026

Journal of Urology Publishes ENVISION Trial Results Showing 72.2% 24-Month Duration of Response with ZUSDURI

Indeterminate GlobeNewswire

Mar. 30, 2026

Aprea Therapeutics Highlights Positive Emerging Clinical Activity for WEE1 Inhibitor, APR-1051, with a Confirmed Partial Response in the Ongoing Phase 1 ACESOT-1051 Trial

Indeterminate GlobeNewswire

Mar. 30, 2026

Nano Labs Announces Second Half of 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 30, 2026

Lotus For Me SUV Officially Launches: Redefining Performance and Versatility with X-Hybrid Technology

Indeterminate GlobeNewswire

Mar. 30, 2026

Fancamp Acquires Iron Ore Royalty and Provides Corporate Update

Indeterminate GlobeNewswire

Mar. 30, 2026

BridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9

Indeterminate GlobeNewswire

Mar. 30, 2026

InflaRx Highlights Clinical Activity of Vilobelimab in Pyoderma Gangrenosum in Late-Breaker Oral Presentation at 2026 American Academy of Dermatology Annual Meeting

Indeterminate GlobeNewswire

Mar. 30, 2026

Connect Biopharma Announces $20.2 Million Private Placement Financing

Indeterminate GlobeNewswire

Mar. 30, 2026

Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study

Indeterminate GlobeNewswire

Mar. 30, 2026

Micron Biomedical Named to Fast Company’s 2026 List of World’s Most Innovative Companies for Addressing the Most Significant Bottlenecks in How Medicine is Made, Distributed and Administered

Indeterminate GlobeNewswire

Mar. 30, 2026

PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement

Indeterminate GlobeNewswire

Mar. 30, 2026

Immusoft Awarded $15 Million in Funding from the California Institute for Regenerative Medicine

Indeterminate GlobeNewswire

Mar. 30, 2026

Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD

Indeterminate GlobeNewswire

Mar. 30, 2026

OROCO ANNOUNCES RESIGNATION OF CEO

Indeterminate GlobeNewswire

Mar. 30, 2026

Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Mar. 30, 2026

Equinox Gold Updates Canadian Operations Technical Outlook: Average 540,000 Ounces Gold Production per Year for Next 10 Years

Indeterminate GlobeNewswire